SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Doug Soon who wrote (3146)6/3/1998 1:18:00 PM
From: Riskmgmt  Read Replies (1) | Respond to of 9523
 
I got a phone call while it was on and missed that. I did hear Faber say that there had been a fall off in subscriptions since the deaths were announced. Typical superficial reporting. However the main thrust of the story seemed to be that viagra had no real competition. He mentioned Zonagen and vivus (s?). So overall, I thought it positive.

Ray



To: Doug Soon who wrote (3146)6/3/1998 1:27:00 PM
From: B.REVERE  Read Replies (2) | Respond to of 9523
 
[cnbc report] -- e-mailed Faber to confirm if this was for
w/e 5/29. Also mentioned that this was a four day week for
pharmacies and urologists and the refill rate(which is really
more important than the overall script rate) was omitted from his report. Will write back what he says if he responds.

Later,


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News